TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin

Autor: Debra M. Townley, Sunila Pradeep, Shelli R. Kesler, Anil K. Sood, Ndidi-Ese Uzor, Lingegowda S. Mangala, Andrey S. Tsvetkov, Jose F. Moruno-Manchon, Archana S. Nagaraja, Jeffrey S. Wefel
Rok vydání: 2016
Předmět:
Zdroj: Aging (Albany NY)
ISSN: 1945-4589
DOI: 10.18632/aging.101144
Popis: Doxorubicin, a commonly used chemotherapy agent, induces severe cardio- and neurotoxicity. Molecular mechanisms of cardiotoxicity have been extensively studied, but mechanisms by which doxorubicin exhibits its neurotoxic properties remain unclear. Here, we show that doxorubicin impairs neuronal autophagy, leading to the accumulation of an autophagy substrate p62. Neurons treated with doxorubicin contained autophagosomes, damaged mitochondria, and lipid droplets. The brains from mice treated with pegylated liposomal doxorubicin exhibited autophagosomes, often with mitochondria, lipofuscin, and lipid droplets. Interestingly, lysosomes were less acidic in doxorubicin-treated neurons. Overexpression of the transcription factor EB (TFEB), which controls the autophagy-lysosome axis, increased survival of doxorubicin-treated neurons. 2-Hydroxypropyl-β-cyclodextrin (HPβCD), an activator of TFEB, also promoted neuronal survival, decreased the levels of p62, and lowered the pH in lysosomes. Taken together, substantial changes induced by doxorubicin contribute to neurotoxicity, cognitive disturbances in cancer patients and survivors, and accelerated brain aging. The TFEB pathway might be a new approach for mitigating damage of neuronal autophagy caused by doxorubicin.
Databáze: OpenAIRE